(Q68094892)

English

Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide

scientific article published on 01 January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

M Hosokawa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Y Sawamura

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

T Morikage

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Z Y Xu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

K Morikawa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

K Itoh

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

H Kobayashi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 January 1988

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

250-256

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

https://scigraph.springernature.com/pub.10.1007/bf00199937

0 references

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of interleukin-2 after in vivo administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of tumor-enhancing cells by cyclophosphamide and its relevance to cyclophosphamide therapy of the murine mammary tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antineoplastic agents on the induction of suppressor macrophages by concanavalin A-bound tumor vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of human interleukin 2 cDNA and its expression inE. coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Chemotherapeutic Agents on Natural Cell-Mediated Cytotoxicity in Mice2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/3260132

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00199937

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3260132%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68094892&oldid=1753258635"